Eledon Pharmaceuticals (ELDN) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Whitehawk Therapeutics (WHWK) has outperformed Eledon Pharmaceuticals (ELDN) over the past year, gaining 62.9% versus a loss of 15.7%. Over five years, ELDN leads with a -57.0% price change compared with -87.2% for WHWK. Eledon Pharmaceuticals is the larger company by market cap ($201.5 million vs $200.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELDN | WHWK |
|---|---|---|
| Share price | $2.48 | $3.52 |
| Market cap | $201.53M | $200.67M |
| 1-day change | +2.48% | +1.44% |
| YTD return | +60.26% | +43.39% |
| 1-year return | -15.68% | +62.91% |
| 5-year return | -57.02% | -87.25% |
| EPS (TTM) | $-0.90 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.60 | $5.50 |
| 52-week low | $1.35 | $1.87 |
| Distance from 52-week high | -46.09% | -35.94% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +262.90% | +119.03% |
| Average volume | 935.08K | 367.72K |
| Shares outstanding | 81.26M | 57.01M |
| Employees | 33 | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WHWK has outperformed ELDN by 78.6 percentage points over the past year.
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
ELDN vs WHWK FAQ
Which is bigger, Eledon Pharmaceuticals or Whitehawk Therapeutics?
Eledon Pharmaceuticals (ELDN) is larger, with a market capitalization of $201.53M compared with $200.67M for Whitehawk Therapeutics (WHWK).
Which stock has performed better over the past year, ELDN or WHWK?
WHWK returned +62.91% over the past 12 months, compared with -15.68% for ELDN (price return, excluding dividends). Past performance does not predict future results.
Are Eledon Pharmaceuticals and Whitehawk Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.